Current through Register Vol. 43, No. 52, December 26, 2024
(a) Any
institution, person, or group of persons meeting the requirements of K.A.R.
28-35-181a or 28-35-181b may file a written application with the secretary for
a specific license to use radioactive material for any group or groups of
medical uses. Each application shall meet the requirements of K.A.R. 28-35-179a
and shall designate the intended group or groups of uses for the radioactive
material.
(b) Each application for
a specific license to use radioactive material for any group or groups of
medical uses shall meet all of the following requirements:
(1) The applicant, or the physician or
physicians designated in the application as the individual user or users, has
adequate clinical experience in performing the medical use or uses for which
application is made.
(2) The
applicant's proposed radiation detection instrumentation is adequate for
conducting the medical procedures specified in the group or groups of uses for
which application is made.
(3) The
applicant's radiation safety operating procedures are adequate for the proper
handling and disposal of radioactive material involved in the group or groups
of uses for which application is made.
(4) The applicant, or the physician or
physicians designated in the application as the individual user or users, and
all other personnel who will be involved in the preparation and use of the
radioactive material have adequate training and experience in the handling of
radioactive material. The training and experience shall be appropriate for the
conduct of the uses included in the group or groups of uses for which
application is made.
(c)
Each licensee who is licensed under this regulation shall be subject to the
following limitations:
(1) A licensee who has
been issued a license for group I, II, IV, or V uses shall not receive,
possess, or use radioactive material, except those radiopharmaceuticals
manufactured in the form to be administered to the patient, and labeled,
packaged, and distributed in accordance with a specific license issued by the
secretary, or the nuclear regulatory commission or an agreement
state.
(2) A licensee who has been
issued a license for group III uses shall not receive, possess, or use
generators or reagent kits containing radioactive material and shall not use
reagent kits that do not contain radioactive material to prepare
radiopharmaceuticals containing radioactive material, except for the following:
(A) Reagent kits not containing radioactive
material that are approved by the secretary, the nuclear regulatory commission,
or an agreement state for use by persons licensed pursuant to this regulation
for group III medical uses; or
(B)
generators or reagent kits containing radioactive material that are
manufactured, labeled, packaged, and distributed in accordance with a specific
license issued by the secretary, the nuclear regulatory commission, or an
agreement state.
(3)
Each licensee who has been issued a license for group III uses and who uses
generators or reagent kits shall elute the generator or process radioactive
material with the reagent kit in accordance with instructions that are approved
by the secretary, the nuclear regulatory commission, or an agreement state and
furnished by the manufacturer on the label attached to, or in the leaflet or
brochure that accompanies, the generator or reagent kit.
(4) Each licensee preparing technetium-99m
radiopharmaceuticals from molybdenum-99 or technetium-99m generators or
rubidium-82 from strontium-82 or rubidi-um-82 generators shall test the
generator eluates for mo-lybdenum-99 breakthrough or for strontium-82 and
stron-tium-85 contamination, respectively, in accordance with part 3 of these
regulations. Each licensee shall record the results of each test and shall
retain each record for three years after the record is made. Each licensee
shall report to the department the results of each test that exceeds the
permissible concentration in accordance with part 3 of these regulations at the
time of generator elution.
(5) Each
licensee who has been issued a license for group I, II, or III uses and who
uses the radioactive material for clinical procedures other than those
specified in the product labeling or package insert shall comply with the
product labeling regarding the following:
(A)
Chemical and physical form;
(B)
route of administration; and
(6) A
licensee who has been issued a license for group IV uses shall not receive,
possess, or use radioactive material unless contained in a source or device
that has been manufactured, labeled, packaged, and distributed in accordance
with a specific license issued by the secretary, the nuclear regulatory
commission, or an agreement state.
(d) Each licensee who is licensed under this
regulation shall be authorized to use radioactive material under the general
license issued in K.A.R. 28-35-178h for the specified in vitro uses, without
filing form RH-31 as otherwise required by that regulation. However, the
licensee shall be subject to the other requirements of K.A.R.
28-35-178h.
(e) Each licensee who
is licensed under this regulation shall be authorized, subject to the
provisions of subsections (f) and (g), to receive, possess, and use the
following for calibration and reference standards:
(1) Any radioactive material listed in group
I, II, or III that has a half-life of 100 days or less, in amounts not
exceeding 15 millicuries;
(2) any
radioactive material listed in group I, II, or III that has a half-life of more
than 100 days, in amounts not exceeding 200 microcuries;
(3) technetium-99m, in amounts not exceeding
30 millicuries; and
(4) any
radioactive material, in amounts not exceeding three millicuries per source,
contained in calibration or reference sources that have been manufactured,
labeled, packaged, and distributed in accordance with a specific license issued
by the secretary, the nuclear regulatory commission, or an agreement
state.
(f)
(1) Each licensee who possesses sealed
sources as calibration or reference sources pursuant to subsection (e) shall
cause each sealed source containing radioactive material, other than
hydrogen-3, that has a half-life of more than 30 days and that is in any form
other than gas to be tested for leakage, contamination, or both at intervals
not exceeding six months. In the absence of a certificate from a transferor
indicating that a leak test has been made within six months before the transfer
of a particular sealed source, that sealed source shall not be used until
tested, unless one of the following conditions is met:
(A) The source contains 100 microcuries or
less of beta-emitting, gamma-emitting, or beta-emitting and gamma-emitting
material, or 10 microcuries or less of alpha-emitting material.
(B) The sealed source is stored and is not
being used.
(2) Each
leak test required by paragraph (f)(1) shall be capable of detecting the
presence of 0.005 microcurie of radioactive material on the test sample. The
test sample shall be taken from sealed source or from the surfaces of the
device in which the sealed source is permanently mounted or stored and on which
contamination might be expected to accumulate. Records of leak test results
shall be kept in units of microcuries and shall be maintained for inspection by
the department.
(3) If the leak
test reveals the presence of 0.005 microcurie or more of removable
contamination, the licensee shall immediately withdraw the sealed source from
use and shall cause it to be decontaminated and repaired, or to be disposed of
in accordance with parts 3 and 4 of these regulations. A report shall be filed
with the secretary within five days of the test, describing the equipment
involved, the test results, and the corrective action taken.
(g) Each licensee who possesses
and uses calibration and reference sources pursuant to subsection (e) shall
perform the following:
(1) Follow radiation
safety and handling instructions that are approved by the secretary, the
nuclear regulatory commission, or an agreement state and furnished by the
manufacturer on the label attached to the source, or permanent container, or in
the leaflet or brochure that accompanies the source;
(2) maintain the instructions referenced in
paragraph (g)(1) in a legible and conveniently available form; and
(3) conduct a quarterly physical inventory to
account for all sources received and possessed. A record of each inventory
shall be maintained for inspection by the department and shall include the
quantities and kinds of radioactive material, location of sources, and the date
of the inventory.